The PredictAD project: development of novel biomarkers and analysis software for early diagnosis of the Alzheimer's disease

  title={The PredictAD project: development of novel biomarkers and analysis software for early diagnosis of the Alzheimer's disease},
  author={Kari Antila and Jyrki L{\"o}tj{\"o}nen and Lennart Thurfjell and Jarmo Laine and Marcello Massimini and Daniel Rueckert and Roman A. Zubarev and Matej Ore{\vs}ič and Mark van Gils and Jussi Mattila and Anja Hviid Simonsen and Gunhild Waldemar and Hilkka Soininen},
  journal={Interface Focus},
Alzheimer's disease (AD) is the most common cause of dementia affecting 36 million people worldwide. As the demographic transition in the developed countries progresses towards older population, the worsening ratio of workers per retirees and the growing number of patients with age-related illnesses such as AD will challenge the current healthcare systems and national economies. For these reasons AD has been identified as a health priority, and various methods for diagnosis and many candidates… 

Figures from this paper

Diagnosis of Alzheimer’s Disease using Multiple Instance Learning
This work aims to present an automatic diagnostic tool based on a recent machine learning field, the Multiple-Instance Learning (MIL) model, which differs from the more common supervised learning paradigm and shows that, although not outperforming other supervised approaches, this paradigm is competitive with the state of the art.
Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers.
The ability of the PredictAD tool to identify AD pathophysiology was comparable to individual biomarkers, allowing clinicians to integrate biomarker data in daily practice.
Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
It is shown that multiple EEG biomarkers mainly related to activity in the beta-frequency range (13–30 Hz) can predict conversion from MCI to AD and this approach can be used to identify optimal combinations of biomarkers (integrative biomarkers) also in other modalities.
Brain investigation and brain conceptualization.
A new approach to earlier diagnosis based on a multimodal and multiscale brain concept, built upon existing and well-characterized single modalities is described.
Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer’s Biomarkers in Daily Practice (ABIDE) Project
This study provides biomarker-based prognostic models that may help determine AD dementia and any type of dementia in patients with MCI at the individual level and supports clinical decision making and application of biomarkers in daily practice.
Dublin City University Use of Machine Learning Technology in the Diagnosis of Alzheimer ’ s Disease
This thesis proposes to use the dataset from the NACC to test the hypothesis that a machine learning classifier can be generated to predict the dementia status for new, previously unseen subjects, and establishes both the minimum number of instances required and the most important features from assessment interviews, to use for this prediction.
A practical computerized decision support system for predicting the severity of Alzheimer’s disease of an individual
A data-driven and self-adaptive computerized clinical decision support system (CDSS) prototype for evaluating the severity of AD of an individual on a continuous spectrum is designed and developed.
Early Diagnosis of Alzheimer's Disease by Joint Feature Selection and Classification on Temporally Structured Support Vector Machine
The evaluation of the proposed flexible spatial-temporal solution for early detection of AD by recognizing abnormal structure changes from longitudinal MR image sequence shows that it is able to alarm the conversion of AD 12 months prior to the clinical diagnosis with at least 82.5 % accuracy.
Exploring of Classification Methods for Early Detection of Alzheimer’s Disease
A review evaluation and critical analysis of the recent research work done to early diagnosis of AD using Machine Learning Strategies is provided.


Software Tool for Improved Prediction of Alzheimer’s Disease
A versatile and objective clinical decision support system that could reduce diagnostic errors and highlight early predictors of Alzheimer's disease based on interpretable visualizations of patient data is developed.
Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects.
It is shown that the disease index values derived from heterogeneous patient data can be used for identifying groups of patients for whom the prediction accuracy reaches the previously set target level.
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
A disease state fingerprint for evaluation of Alzheimer's disease.
The results suggest that the DSF establishes an effective decision support and data visualization framework for improving AD diagnostics, allowing clinicians to rapidly analyze large quantities of diverse patient data.
Metabolome in progression to Alzheimer's disease
The findings primarily implicate hypoxia, oxidative stress, as well as membrane lipid remodeling in progression to AD.
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade